3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Withdrawn
1
Completed
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Hepatitis C
1
Carcinoma, Hepatocellular
1
Interventions
elbasvir-grazoprevir drug combination
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Hepatitis C
×
elbasvir-grazoprevir drug combination
×
Clear all
NCT04546802
2020-09-14
HATCHeT
Bayside Health
Phase 3
Withdrawn